SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001847903-23-000029
Filing Date
2023-01-13
Accepted
2023-01-13 17:46:24
Documents
1
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_167364997060589.html 4  
1 FORM 4 wf-form4_167364997060589.xml 4 5222
  Complete submission text file 0001847903-23-000029.txt   6770
Mailing Address 3RD FLOOR 1 ASHLEY ROAD ALTRINCHAM, CHESHIRE X0 WA14 2DT
Business Address 3RD FLOOR 1 ASHLEY ROAD ALTRINCHAM, CHESHIRE X0 WA14 2DT 44 7391 789784
Centessa Pharmaceuticals plc (Issuer) CIK: 0001847903 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O CENTESSA PHARMACEUTICALS PLC 3RD FL., 1 ASHLEY RD, ALTRINCHAM CHESHIRE X0 WA14 2DT
Business Address
GRAINGER DAVID J (Reporting) CIK: 0001887115 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40445 | Film No.: 23529788